These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1280 related items for PubMed ID: 10893575

  • 1. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB, Blute ML, Spotts B, Zincke H.
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [Abstract] [Full Text] [Related]

  • 2. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V, McDonald M, Tamboli P, Swanson DA, Wood CG.
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [Abstract] [Full Text] [Related]

  • 3. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.
    Schrodter S, Hakenberg OW, Manseck A, Leike S, Wirth MP.
    J Urol; 2002 Apr; 167(4):1630-3. PubMed ID: 11912377
    [Abstract] [Full Text] [Related]

  • 4. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
    Canfield SE, Kamat AM, Sánchez-Ortiz RF, Detry M, Swanson DA, Wood CG.
    J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
    [Abstract] [Full Text] [Related]

  • 5. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
    Hafez KS, Novick AC, Campbell SC.
    J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
    [Abstract] [Full Text] [Related]

  • 6. Management of isolated renal fossa recurrence following radical nephrectomy.
    Master VA, Gottschalk AR, Kane C, Carroll PR.
    J Urol; 2005 Aug; 174(2):473-7; discussion 477. PubMed ID: 16006867
    [Abstract] [Full Text] [Related]

  • 7. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S, Bagga HS, Romero FR, Sroka M, Jarrett TW, Kavoussi LR.
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [Abstract] [Full Text] [Related]

  • 8. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [Abstract] [Full Text] [Related]

  • 9. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H.
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [Abstract] [Full Text] [Related]

  • 10. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ, Cookson MS, Chapman W, Harrell F, Wells N, Chang SS, Smith JA.
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [Abstract] [Full Text] [Related]

  • 11. Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival.
    Bruno JJ, Snyder ME, Motzer RJ, Russo P.
    BJU Int; 2006 May; 97(5):933-8. PubMed ID: 16643473
    [Abstract] [Full Text] [Related]

  • 12. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [Abstract] [Full Text] [Related]

  • 13. Single center preliminary experience with hand-assisted laparoscopic resection of isolated renal cell carcinoma fossa recurrences.
    Bandi G, Wen CC, Moon TD, Nakada SY.
    Urology; 2008 Mar; 71(3):495-9; discussion 499-500. PubMed ID: 18342195
    [Abstract] [Full Text] [Related]

  • 14. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
    Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML.
    J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
    [Abstract] [Full Text] [Related]

  • 15. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
    Levy DA, Slaton JW, Swanson DA, Dinney CP.
    J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
    [Abstract] [Full Text] [Related]

  • 16. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H.
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [Abstract] [Full Text] [Related]

  • 17. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M, Minervini A, Lapini A, Masieri L, Serni S.
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
    Patel A, Soonawalla P, Shepherd SF, Dearnaley DP, Kellett MJ, Woodhouse CR.
    J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
    [Abstract] [Full Text] [Related]

  • 19. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M.
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [Abstract] [Full Text] [Related]

  • 20. 7-year oncological outcomes after laparoscopic and open partial nephrectomy.
    Lane BR, Gill IS.
    J Urol; 2010 Feb; 183(2):473-9. PubMed ID: 20006866
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 64.